Sales are up more than 50% for the first nine months of 2008 for radiopharmaceutical firm Ion Beam Applications (IBA), but the bottom line is expected to take a hit.
In its interim third-quarter report, the Louvain-la-Neuve, Belgium, company said the advance in sales is due to internal growth and its June acquisition of Cisbio Bioassays of France. Cisbio's U.S headquarters is in Bedford, MA.
IBA also noted that profit is expected to decrease for the nine-month period, due to restructuring and costs related to integrating Cisbio.
Copyright © 2008 AuntMinnie.com